
Opinion|Podcasts|December 13, 2024
Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management
Key Takeaways
Panelists discuss how bempedoic acid offers a promising alternative for patients who are statin-intolerant, demonstrating efficacy in reducing major cardiovascular events and low-density lipoprotein cholesterol, while addressing its role in managing residual cardiovascular risk, particularly in high-risk populations.
Advertisement
Exploring Bempedoic Acid: Clinical Indications, Efficacy, and Future Directions in Cardiovascular Risk Management
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Diabetes Increases Mortality Risk Across All Major Organ Transplants
2
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
3
Plasma EV Analysis Identifies Proteins Associated With T1D Risk, With Ernesto Nakayasu, PhD
4
How to Counsel Patients About Skincare Safety, Sunscreen Safety, and Product Ingredients
5



























































